Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D Target Genes and Circadian Gene-List Overlap: Full Study

Previous related pageVitamin D Target Genes and Circadian Gene-List Overlap: Study SummaryNext related pageFrom Vitamin D Gene Responses to Circadian Timing
Study at a glance

What did researchers compare about vitamin D and daily gene rhythms?

Researchers compared genes that responded to vitamin D in blood cells with separate lists of genes showing daily or seasonal changes. The vitamin D study involved 25 healthy Finnish adults, sampled before and 24 hours after a one-day vitamin D3 treatment. The daily and seasonal lists came from different people in other studies.

How many vitamin D-responsive genes appeared on the daily-rhythm list?

Of 361 vitamin D-responsive genes, 87 also appeared on the daily-rhythm list. This overlap was greater than expected by chance under the study’s analysis. The seasonal overlap was not statistically significant. Among the 87 overlapping genes, 17 increased and 70 decreased in activity. The finding therefore did not mean vitamin D increased the activity of all these genes or made them follow a daily rhythm.

Did people’s genes respond to vitamin D in different ways?

The researchers found different patterns of gene response among participants and divided them into two groups. These groups were created from the same small dataset and were not groups confirmed by separate research that could be used to choose treatment. Additional vitamin D receptor evidence came from a separate cell-line study, not from direct receptor measurements in the participants’ brains or blood cells.

Does the gene overlap show a change in sleep or the body clock?

Two blood samples taken 24 hours apart cannot show a change in the timing, strength or length of a daily rhythm. Gene-list overlap does not prove that the body clock was reset. The study did not measure sleep or compare taking vitamin D in the morning with taking it in the evening. It does not establish better sleep, a personalised supplement dose or the best time to take vitamin D.

Read the full article below ↓

Vitamin D-responsive genes in human blood cells overlapped more than expected with a separate list of genes showing daily variation. This is evidence of a molecular connection, but it does not show that vitamin D reset participants’ clocks, improved their sleep or worked better at a particular dosing time. For the shorter account, see Vitamin D Target Genes and Circadian Gene-List Overlap: Study Summary.

This VD3FL analysis uses the complete principal article, its figures, three supplementary figures and two supplementary workbooks. The study concerns blood-cell gene expression.

The question behind the gene-list comparison

Maissan and Carlberg asked whether genes responding to vitamin D were disproportionately represented among genes previously associated with circadian or seasonal variation. They also examined whether participants differed in their gene responses. These are questions about the organisation of molecular data, not direct tests of sleep treatment.

The distinction matters for Vitamin D and Circadian Biology. A gene can respond to an intervention and also appear on a circadian list without the intervention changing that gene’s rhythm. Establishing a change in rhythm requires measurements across time that can distinguish phase, amplitude or period. Membership of two lists alone supplies none of those quantities.

The study is useful because it connects a defined human vitamin D experiment with independently generated timing datasets. Its value depends on keeping the experiments separate in the interpretation. Participants in the vitamin D study were not all observed under the circadian and seasonal protocols used to construct the comparison lists.

What happened in the vitamin D experiment?

The analysis used the VitDHiD intervention dataset from 25 healthy Finnish adults aged 20-54, including 12 women and 13 men. Their body mass index ranged from 21.4 to 25.6. This was a small, selected group, rather than a representative sample of people with insomnia, shift-work difficulties or chronic illness.

Participants received a total of 80,000 IU of oral vitamin D3 on one day, divided into 40,000 IU at breakfast and lunch. These amounts describe an experimental protocol, not a recommendation. Blood was collected before the intervention and 24 hours later, and RNA was analysed in peripheral blood mononuclear cells, commonly abbreviated PBMCs.

The comparison concerns transcript abundance in a mixed population of immune cells. It does not directly measure protein production, enzyme activity or the behaviour of the central circadian clock. The broader topic of Vitamin D and Gene Expression helps separate a change in RNA from a completed physiological effect.

There were 50 blood-cell samples across the two measurements. The researchers identified 7,665 genes meeting their robust-expression criteria and 361 vitamin D-responsive genes at a false discovery rate of no more than .05. The expression background matters: enrichment is judged relative to the genes eligible for analysis, not simply every gene in the human genome.

False discovery rate control addresses multiplicity across many gene tests under the analysis assumptions. It does not mean that each selected gene has a 95% probability of being causal, or that every selected effect will reproduce at the same size in another population. Selection and replication remain different stages.

Where the timing information came from

The circadian comparison list came from a separate whole-blood experiment involving 26 people, sampled every three hours across 30 hours after a week of sufficient or restricted sleep. Maissan and Carlberg used the sufficient-sleep condition. The seasonal list came from another study involving 105 people followed across four years.

Within the robust-expression background, 873 genes were classified as circadian and 363 as seasonal. Whole blood and PBMC preparations contain different mixtures of cells. Differences in sample composition, study population, assay context and analysis can therefore influence the overlap between lists.

Daily variation and seasonal variation are also distinct. A response associated with Vitamin D and Season is not automatically a daily clock effect. Likewise, a gene’s presence on a circadian list does not prove that it is a central clock component. Many genes can show rhythmic expression downstream of clock regulation or changing physiology.

The paper combined published datasets to ask a new question. It did not create a single experiment that measured vitamin D intervention, sleep restriction and four years of seasonal exposure in the same people. Treating those datasets as one longitudinal trial would give the evidence a causal coherence it does not have.

The main overlap result

Of the 361 vitamin D targets, 87 overlapped the circadian list and 18 overlapped the seasonal list. Six appeared in all three categories. The circadian overlap was statistically enriched, with a reported hypergeometric P value of approximately 1.20 × 10⁻¹². The seasonal overlap was not significant, P=.4233.

The enrichment test asks whether the observed overlap is greater than expected under its reference model. It does not show that the vitamin D intervention made 87 genes rhythmic, moved their peak expression earlier, or strengthened an existing oscillation. None of those changes can be inferred from two samples taken 24 hours apart.

The direction of response also deserves attention. Of the 87 overlapping genes, 17 increased and 70 decreased in expression. Describing the result as activation or boosting of 87 clock genes would therefore misstate both the direction and the type of evidence.

A lower transcript level is not intrinsically harmful, just as a higher level is not intrinsically beneficial. Biological interpretation depends on the gene, cell, timing and downstream effects. The study provides expression differences, not a score in which more expression automatically means better health. This is a specific example of the distinctions within Vitamin D Response.

Individual differences and network analysis

The investigators grouped correlated gene responses into six clusters and examined their relationships using STRING. Such network edges can represent known or predicted functional associations as well as physical interactions. They should not be read as newly demonstrated arrows showing vitamin D travelling through a causal pathway in these participants.

A separate clustering analysis divided the 25 participants into groups of nine and sixteen. Fourteen target responses differed between the groups. These clusters were derived from the same small dataset being described, rather than being prospectively validated clinical categories.

The paper’s language of individual responsiveness is therefore about heterogeneous molecular responses. It does not establish a test for selecting a personal supplement dose, identify chronotypes, or show that a person in one cluster will sleep better after treatment. Such claims would require independent validation and clinically relevant outcomes.

The connection with Vitamin D Genetics is limited: inherited variation can be relevant to vitamin D biology, but this clustering result should not be renamed a genetic classification. The analysis grouped observed gene-expression responses; it did not establish that a particular inherited variant caused each person’s response pattern.

What the receptor analysis adds

The paper also considered nearby vitamin D receptor binding and accessible chromatin using previously generated THP-1 cell-line data. Those experiments exposed cells to 10 nM calcitriol or vehicle at two and 24 hours. They were not receptor measurements from the brains or blood cells of the 25 intervention participants.

Candidate regulatory regions were sought within one megabase of target genes, with identified regions between roughly two and 455 kilobases away. Proximity provides a basis for investigating regulation, but does not prove that a particular enhancer produced the measured gene response in the human intervention.

This distinction is central to Vitamin D Receptors and Vitamin D Signalling Pathways. Evidence that a receptor can bind near a gene is different from demonstrating the complete chain from exposure to binding, transcription, rhythmic behaviour and a clinical outcome in one experiment.

The cell-line evidence and human blood-cell evidence are complementary, but they remain different layers. The study did not directly perturb the proposed regulatory regions in participants. It therefore supports a mechanistic hypothesis while leaving important causal steps untested.

A naming inconsistency that affects interpretation

The main text alternates between CSRNP1 and CSRNP2. The figure and supplementary workbook identify CSRNP1 among the relevant circadian targets. In the workbook, CSRNP1 meets the circadian false-discovery criterion whereas CSRNP2 does not. This analysis follows the checked figure and workbook rather than silently treating the names as interchangeable.

The supplementary legends also use a .10 false-discovery threshold for some highlighting, while the principal results use .05. The larger highlighted set is not the same as the stricter main-result subset. Comparing lists without their thresholds can manufacture an apparent disagreement or overstate how many results met the principal criterion.

These issues do not erase the overall enrichment finding. They do mean that gene-level claims need to be tied to the actual table, threshold and contrast being discussed. No raw sequencing reanalysis was performed for this article; the assessment checks the published evidence and its internal consistency.

What this study cannot say about sleep or dosing time

There was no randomised morning-versus-evening dosing comparison. Breakfast and lunch describe when the experimental doses were given, not evidence that those times were superior. There was also no sleep endpoint, chronotype assessment or within-person circadian time series in the vitamin D intervention.

The link to Vitamin D and Sleep: Wake Regulation is consequently a research question, not a demonstrated improvement in sleep-wake regulation. Similarly, this paper cannot establish that supplementation offsets Artificial Light and Vitamin D Rhythm Disruption. Light exposure and vitamin D-related molecular responses should not be presented as interchangeable timing signals.

Two measurements separated by 24 hours can detect a change at the sampled times but cannot describe the intervening curve. A phase shift, a sustained expression change and other time-dependent responses can produce different underlying patterns that are invisible with this sampling design.

The authors declare no conflicts and report public and foundation research support. Those declarations do not change the design limits. The appropriate next scientific question is whether the overlap predicts reproducible changes in directly measured rhythms or relevant outcomes, not which clock time readers should choose for supplementation.

Conclusion

The analysis identifies enriched overlap between vitamin D-responsive blood-cell genes and an external circadian gene list, alongside variation between individuals. It supports further study of a molecular connection. It does not demonstrate clock resetting, better sleep, validated personalised treatment or an optimal time to take vitamin D.

Scientific sources

Maissan P, Carlberg C. Circadian Regulation of Vitamin D Target Genes Reveals a Network Shaped by Individual Responsiveness. Nutrients. 2025;17(7):1204. DOI 10.3390/nu17071204; PMID 40218962.

Related reading

Physiology

Vitamin D and Circadian Biology

Explains how vitamin D relates to circadian biology, including links with light exposure, hormone timing, metabolism, immune rhythms, and sleep: wake regulation, without making treatment claims.

Read more →

Original sources